![](/img/cover-not-exists.png)
Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of alzheimer's disease
Ronald J. PolinskyVolume:
20
Year:
1998
Language:
english
DOI:
10.1016/s0149-2918(98)80127-6
File:
PDF, 1.27 MB
english, 1998